Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian CancerDale W. Garsed, Kathryn Alsop, Sián Fereday et al.|Clinical Cancer Research|2017Cited by 95
PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumorsMónica Tang, Michael Friedländer, Rachel O’Connell et al.|Gynecologic Oncology|2019Cited by 88
A Phase I clinical and pharmacological study of cis-diamminedichloro(2-methylpyridine) platinum II (AMD473)Philip Beale, L Etterley|British Journal of Cancer|2003Cited by 44
Patterns of platinum drug use in an acute care setting: a retrospective studyEvangeline Armstrong-Gordon, Nial Wheate, Danijela Gnjidic et al.|Journal of Cancer Research and Clinical Oncology|2018Cited by 31
Paragon (ANZGOG-0903)Anthony Bonaventura, Michael Friedländer, Rachel O’Connell et al.|International Journal of Gynecological Cancer|2017Cited by 22